ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORSMESMMAKHTNMDGE........*X0009010-RPUB024815943A120261007EP24901401.02024120320260623enenen202363605555 P20231203US2026100720264120261007202641A61K 31/395 20060101AFI20250614BHEP C07D 401/14 20060101ALI20250614BHEP C07D 403/04 20060101ALI20250614BHEP A61K 31/33 20060101ALI20250614BHEP C07D 409/14 20130101 FI20250715BHEP C07D 421/14 20130101 LI20250715BHEP C07D 491/056 20130101 LI20250715BHEP C07D 495/04 20130101 LI20250715BHEP C07D 497/04 20130101 LI20250715BHEP A61K 31/407 20130101 LI20251009BHEP deBENZOTHIOPHEN-3-YL- UND BENZOSELENOPHEN-3-YL (BICYCLISCHES HETEROARYL) MALEINIMIDE ALS GSK-3-HEMMERenBENZOTHIOPHENE-3-YL- AND BENZOSELENOPHENE-3-YL (BICLYCLIC HETEROARYL) MALEMIDES AS GSK-3 INHIBITORSfrMALÉMIDES DE BENZOTHIOPHÈNE-3-YL ET BENZOSÉLÉNOPHÈNE-3-YL (HÉTÉROARYLE BICLYLIQUE) EN TANT QU'INHIBITEURS DE GSK-31Mayo Foundation for Medical Education and Research101868588PA112138EP01200 First Street SWRochester, MN 55905-0001USTUECKMANTEL, WernerFitchburg, WI 53713USKOZIKOWSKI, AlanWallace, MI 49893USBILLADEAU, Daniel DenisRochester, Minnesota 55901USStudio Torta S.p.A.101577269Via Viotti, 910121 TorinoITALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMEMKMTNLNOPLPTRORSSESISKSMTRBAGEKHMAMDTNUS202405826920241203enWO202512250120250612202524